Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
Conditions: Healthy Volunteers Interventions: Biological: Inactivated rotavirus vaccine (low dose); Biological: Inactivated rotavirus vaccine (high dose); Biological: Placebo Sponsors: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants
Conditions: Gastroenteritis Interventions: Combination Product: HRV PCV-free; Combination Product: IPV Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
Conditions: Rotavirus Infection of Children Interventions: Biological: ROTAVAC 5D; Other: Placebo Sponsors: Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Phase II Clinical Trial of the Inactivated Rotavirus Vaccine
Conditions: Rotavirus Infections; Diarrhea Interventions: Biological: IRV on a 0- and 28-day schedule; Biological: IRV on a 0-, 28- and 56-day schedule; Biological: Placebo on Day 0, 28; Biological: Placebo on Day 0, 28, 56 Sponsors: Institute of Medical Biology, Chinese Academy of Medical Sciences; Henan Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
Condition: Rotavirus Gastroenteritis Interventions: Drug: ROTAVAC 5D; Drug: Placebo Sponsors: University of Chile; Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
Conditions: Rotavirus Infections; Rotavirus Gastroenteritis Interventions: Biological: Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine; Biological: High dose Recombinant Trivalent Subunit Rotavirus Vaccine; Biological: Placebo Sponsors: MAXVAX Biotechnology Limited Liability Company; Henan Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials
